ALERT: We are aware of instances where individuals and groups have impersonated Premji Invest employees - often via WhatsApp groups or other online platforms - to provide fraudulent investment advice. Please note that Premji Invest group does not offer investment advisory services to any retail or institutional investors. We urge you to exercise caution and report such activity via the
National Cyber Crime Reporting Portal.
Please note that Premji Invest has no social media presence other than on LinkedIn. Our LinkedIn profile is
https://www.linkedin.com/company/premji-invest/
OK
Back to full portfolio

IPO - BCAX

Oncology therapeutics company developing novel bifunctional antibodies for treatment of solid tumors.
WEBSITE
“Premji Invest has been an early supporter of Bicara from the beginning, having participated in both our Series A and Series B financing. With their support, Bicara is moving forward with urgency towards delivering potential new treatment options to patients struggling with head and neck cancers.”
Claire Mazumdar
CEO, Bicara Therapeutics Inc.
Claire Mazumdar
Founder(s)
Claire Mazumdar
THEME(S)
No items found.
SECTOR(S)
Healthcare
Investment Stage
Early
Company Status
IPO/Public
Bicara

Perspectives

More about Bicara

No items found.